These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 9636497

  • 1. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Kanematsu A, Kitani R, Fuchinoue S, Oshima T, Yagisawa T, Toma H.
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract] [Full Text] [Related]

  • 2. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K, Saito K, Sonda K, Nakagawa Y, Katagiri A, Tomita Y, Tanigawa T, Takeda M.
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression.
    Tanabe K, Tokumoto T, Ishikawa N, Shimizu T, Okuda H, Ito S, Shimmura H, Inui M, Harano M, Manu M, Shiroyanagi Y, Yagisawa T, Nakajima I, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1711-3. PubMed ID: 11119903
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L, Wang Y, Fu SJ, Cheng XJ.
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract] [Full Text] [Related]

  • 12. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA.
    Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Nov; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G, Rosen A, Loreto-Grand B, Burke G, Siquijor A, Luque C, Esquenazi V, Miller J.
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract] [Full Text] [Related]

  • 17. FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
    Hattori R, Ohshima S, Ono Y, Fujita T, Kinukawa T, Matsuura O.
    Transplant Proc; 1998 Nov; 30(7):3801-3. PubMed ID: 9838666
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression.
    Tanabe K, Ishida H, Tokumoto T, Shimmura H, Toda F, Omoto K, Makiyama K, Yagisawa T, Fuchinoue S, Teraoka S, Toma H.
    Transplant Proc; 2002 Aug; 34(5):1668-70. PubMed ID: 12176528
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.